» Authors » Jill Thompson

Jill Thompson

Explore the profile of Jill Thompson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 163
Citations 3914
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kambach S, Bruelheide H, Comita L, Condit R, Wright S, Aguilar S, et al.
Ecology . 2025 Jan; 106(1):e4527. PMID: 39844593
All species must partition resources among the processes that underly growth, survival, and reproduction. The resulting demographic trade-offs constrain the range of viable life-history strategies and are hypothesized to promote...
2.
Ashman M, Clibbens N, Thompson J, Gilburt H, Thompson E, Khalid Y
Res Involv Engagem . 2024 Dec; 10(1):130. PMID: 39696560
Patient and Public Involvement (PPI) is considered good practice in all health research including literature reviews. Reporting of involvement practice in realist reviews has been inconsistent leaving gaps in understanding...
3.
Vile R, Pulido J, Chen A, Kendall B, Tonne J, Metko M, et al.
Res Sq . 2024 Nov; PMID: 39606441
T cell immune tolerance is established in part through the activity of the Auto-immune Regulator (AIRE) transcription factor in the medullary Thymic Epithelial Cells (mTEC) of the thymus. AIRE induces...
4.
Chisholm R, Fung T, Anderson-Teixeira K, Bourg N, Brockelman W, Bunyavejchewin S, et al.
Proc Biol Sci . 2024 Nov; 291(2035):20240486. PMID: 39564678
Populations of forest trees exhibit large temporal fluctuations, but little is known about the synchrony of these fluctuations across space, including their sign, magnitude, causes and characteristic scales. These have...
5.
Metko M, Tonne J, Veliz Rios A, Thompson J, Mudrick H, Masopust D, et al.
Vaccines (Basel) . 2024 Oct; 12(10). PMID: 39460356
Background: Long-lived, re-activatable immunity to SARS-CoV-2 and its emerging variants will rely on T cells recognizing conserved regions of viral proteins across strains. Heterologous prime-boost regimens can elicit elevated levels...
6.
Spencer G, Smith M, Hoare K, Fouche C, Thompson J
J R Soc N Z . 2024 Oct; 52(1):25-37. PMID: 39440008
Migration is a key social determinant of health affecting children's life chances and health outcomes. Yet, relatively little is known about young migrants' own health experiences. This paper reports findings...
7.
Swanson J, Tonne J, Sangsuwannukul T, Thompson J, Kendall B, Liseth O, et al.
Mol Ther Oncol . 2024 Oct; 32(4):200873. PMID: 39403625
Chimeric antigen receptor (CAR) T cells are a clinically approved therapy for blood cancers. To produce clinical-grade CAR T cells, a retroviral or lentiviral vector is used to deliver the...
8.
Tonne J, Budzik K, Carrasco T, Ebbert L, Thompson J, Nace R, et al.
Mol Ther Oncol . 2024 Sep; 32(3):200852. PMID: 39220111
Chimeric antigen receptor (CAR) T cells have had limited success against solid tumors. Here, we used an oncolytic foamy virus (oFV) to display a model CAR target antigen (CD19) on...
9.
Reid J, Gildea E, Davies V, Thompson J, Scott M
Front Vet Sci . 2024 Aug; 11:1395360. PMID: 39205806
Background: Osteoarthritis causes chronic pain, impaired joint function, decreased mobility and negatively impacts quality of life (QOL). Anti-nerve growth factor antibodies bedinvetmab for dogs and frunevetmab for cats are licensed...
10.
Webb M, Sangsuwannukul T, van Vloten J, Evgin L, Kendall B, Tonne J, et al.
Nat Commun . 2024 Jun; 15(1):5442. PMID: 38937436
Although patients benefit from immune checkpoint inhibition (ICI) therapy in a broad variety of tumors, resistance may arise from immune suppressive tumor microenvironments (TME), which is particularly true of hepatocellular...